Data from Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer
Authors:
- Massimo CristofanilliMCMassimo Cristofanilli
- Vicente ValeroVVVicente Valero
- Aroop MangalikAMAroop Mangalik
- Melanie RoyceMRMelanie Royce
- Ian RabinowitzIRIan Rabinowitz
- Francis P. ArenaFAFrancis P. Arena
- Joan F. KroenerJKJoan F. Kroener
- Elizabeth CurcioECElizabeth Curcio
- Claire WatkinsCWClaire Watkins
- Sarah BacusSBSarah Bacus
- Elsa M. CoraECElsa M. Cora
- Elizabeth AndersonEAElizabeth Anderson
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)